Please complete this form relating to your transactions in Doximity, Inc. (NYSE: DOCS) between November 11, 2022 and August 8, 2023.
You may also contact Jonathan Naji, Esq. (484) 270-1453; or you may submit your information via email at email@example.com; or you may click here to print a PDF of this form.
Doximity investors may receive additional information about the investigation by clicking the link "Submit Your Information" above.
Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of purchasers of Doximity, Inc. (NYSE: DOCS) (“Doximity”) securities.
On August 8, 2023, Doximity reported first quarter 2024 financial results, revenues and revised guidance for fiscal 2024. In the report, Doximity disclosed that company now expects lower revenue of $452M-$468M, versus the prior estimate and expectations of $503M. Following this news, the price of Doximity stock fell over 25%, to close at $25.30 per share on August 9, 2023.
If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or via e-mail at firstname.lastname@example.org.